热门资讯> 正文
2025-11-06 21:34
Quoin Pharmaceuticals (NASDAQ: QNRX) reported quarterly losses of $(6.71) per share which missed the analyst consensus estimate of $(6.50) by 3.15 percent. This is a 59.21 percent increase over losses of $(16.45) per share from the same period last year.